|
Lymphoid Neoplasia
Citations 61-70 of 299 total displayed.
|
Past content
(since Jan 2009):
|
The importance of bone marrow examination in determining complete response to therapy in patients with multiple myeloma
- Cheng E. Chee, Shaji Kumar, Dirk R. Larson, Robert A. Kyle, Angela Dispenzieri, Morie A. Gertz, Colin L. Colby, and S. Vincent Rajkumar
Blood 2009; 114: 2617-2618.
[Abstract]
[Full text]
[PDF]
Mer receptor tyrosine kinase is a novel therapeutic target in pediatric B-cell acute lymphoblastic leukemia
- Rachel M. A. Linger, Deborah DeRyckere, Luis Brandão, Kelly K. Sawczyn, Kristen M. Jacobsen, Xiayuan Liang, Amy K. Keating, and Douglas K. Graham
Blood 2009; 114: 2678-2687.
[Abstract]
[Full text]
[PDF]
Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia
- Lisa J. Russell, Melania Capasso, Inga Vater, Takashi Akasaka, Olivier A. Bernard, Maria Jose Calasanz, Thiruppavaii Chandrasekaran, Elise Chapiro, Stephan Gesk, Mike Griffiths, David S. Guttery, Claudia Haferlach, Lana Harder, Olaf Heidenreich, Julie Irving, Lyndal Kearney, Florence Nguyen-Khac, Lee Machado, Lynne Minto, Aneela Majid, Anthony V. Moorman, Heather Morrison, Vikki Rand, Jonathan C. Strefford, Claire Schwab, Holger Tönnies, Martin J. S. Dyer, Reiner Siebert, and Christine J. Harrison
Blood 2009; 114: 2688-2698.
[Abstract]
[Full text]
[PDF]
Aurora kinase A is a target of Wnt/β-catenin involved in multiple myeloma disease progression
- Jui Dutta-Simmons, Yunyu Zhang, Gullu Gorgun, Moshe Gatt, Mala Mani, Teru Hideshima, Kohichi Takada, Nicole E. Carlson, Daniel E. Carrasco, Yu-Tzu Tai, Noopur Raje, Anthony G. Letai, Kenneth C. Anderson, and Daniel R. Carrasco
Blood 2009; 114: 2699-2708.
[Abstract]
[Full text]
[PDF]
Identification of cancer stem cells in a Tax-transgenic (Tax-Tg) mouse model of adult T-cell leukemia/lymphoma
- Jumpei Yamazaki, Takuo Mizukami, Kazuya Takizawa, Madoka Kuramitsu, Haruka Momose, Atsuko Masumi, Yasushi Ami, Hideki Hasegawa, William W. Hall, Hajime Tsujimoto, Isao Hamaguchi, and Kazunari Yamaguchi
Blood 2009; 114: 2709-2720.
[Abstract]
[Full text]
[PDF]
Therapeutic potential of an anti-CD79b antibody–drug conjugate, anti–CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma
- David Dornan, Fiona Bennett, Yvonne Chen, Mark Dennis, Dan Eaton, Kristi Elkins, Dorothy French, Mary Ann T. Go, Andrew Jack, Jagath R. Junutula, Hartmut Koeppen, Jeffrey Lau, Jacqueline McBride, Andy Rawstron, Xiaoyan Shi, Nancy Yu, Shang-Fan Yu, Peng Yue, Bing Zheng, Allen Ebens, and Andrew G. Polson
Blood 2009; 114: 2721-2729.
[Abstract]
[Full text]
[PDF]
A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma
- Mark P. Purdue, Qing Lan, Otoniel Martinez-Maza, Martin M. Oken, William Hocking, Wen-Yi Huang, Dalsu Baris, Betty Conde, and Nathaniel Rothman
Blood 2009; 114: 2730-2732.
[Abstract]
[Full text]
[PDF]
How I treat Waldenström macroglobulinemia
- Steven P. Treon
Blood 2009; 114: 2375-2385.
[Abstract]
[Full text]
[PDF]
Human T-cell leukemia virus type 2 produces a spliced antisense transcript encoding a protein that lacks a classic bZIP domain but still inhibits Tax2-mediated transcription
- Marilène Halin, Estelle Douceron, Isabelle Clerc, Chloé Journo, Nga Ling Ko, Sébastien Landry, Edward L. Murphy, Antoine Gessain, Isabelle Lemasson, Jean-Michel Mesnard, Benoît Barbeau, and Renaud Mahieux
Blood 2009; 114: 2427-2438.
[Abstract]
[Full text]
[PDF]
The IKK2/NF- B pathway suppresses MYC-induced lymphomagenesis
- Kay Klapproth, Sandrine Sander, Dragan Marinkovic, Bernd Baumann, and Thomas Wirth
Blood 2009; 114: 2448-2458.
[Abstract]
[Full text]
[PDF]
|
|
